Profile image
Professor

Professor Kathy Petoumenos

Biostatistics and Databases Program
Phone
+61 (0)2 9385 0900
E-mail
kpetoumenos@kirby.unsw.edu.au
Han WM; Broom J; Bopage R; Templeton DJ; Edmiston N; Petoumenos K, 2024, 'Investigating rates and predictors of viral blips, low-level viraemia and virological failure in the Australian HIV observational database', Tropical Medicine and International Health, 29, pp. 42 - 56, http://dx.doi.org/10.1111/tmi.13951
2024
Byonanebye DM; Polizzotto MN; Maltez F; Rauch A; Grabmeier-Pfistershammer K; Wit F; De Wit S; Castagna A; d'Arminio Monforte A; Mussini C; Wasmuth JC; Fontas E; Abela I; Sarcletti M; Bansi-Matharu L; Jaschinski N; Peters L; Hosein SR; Vannappagari V; Cohen C; Bissio E; Mocroft A; Law M; Ryom L; Petoumenos K, 2024, 'Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts', The Lancet HIV, 11, pp. e321 - e332, http://dx.doi.org/10.1016/S2352-3018(23)00328-4
2024
Mørup SB; Leung P; Reilly C; Sherman BT; Chang W; Milojevic M; Milinkovic A; Liappis A; Borgwardt L; Petoumenos K; Paredes R; Mistry SS; MacPherson CR; Lundgren J; Helleberg M; Reekie J; Murray DD, 2024, 'The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants', AIDS Research and Therapy, 21, http://dx.doi.org/10.1186/s12981-024-00610-x
2024
Nyein PP; Petoumenos K; Borok M; Eriobu N; Kumarasamy N; Avihingsanon A; Azwa I; Dao S; Cisse M; Dharan NJ; Hanson J; Matthews GV, 2024, 'Associations between antiretroviral regimen and changes in blood pressure: results from the D2EFT study.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciae256
2024
Hutchinson J; Neesgard B; Kowalska J; Grabmeier-Pfistershammer K; Johnson M; Kusejko K; De Wit S; Wit F; Mussini C; Castagna A; Stecher M; Pradier C; Domingo P; Carlander C; Wasmuth J; Chkhartishvili N; Uzdaviniene V; Haberl A; d'Arminio Monforte A; Garges H; Gallant J; Said M; Schmied B; van der Valk M; Konopnicki D; Jaschinski N; Mocroft A; Greenberg L; Burns F; Ryom L; Petoumenos K, 2024, 'Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men', HIV Medicine, 25, pp. 1058 - 1074, http://dx.doi.org/10.1111/hiv.13662
2024
King JM; Dobbins T; Keen P; Cornelisse VJ; Stoové M; Nigro SJ; Asselin J; Higgins N; Mao L; Aung HL; Petoumenos K; McGregor S, 2024, 'Trends in HIV testing and HIV stage at diagnosis among people newly diagnosed with HIV', AIDS, 38, pp. 1774 - 1782, http://dx.doi.org/10.1097/QAD.0000000000003961
2024
Nyein PP; Petoumenos K; Dharan NJ; Hanson J; Matthews GV, 2024, 'Refining our understanding of the association between integrase inhibitor therapy and elevations in blood pressure.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciae345
2024
Callander D; McManus H; Gray RT; Grulich AE; Carr A; Hoy J; Donovan B; Fairley CK; Holt M; Templeton DJ; Liaw S-T; McMahon JM; Asselin J; Petoumenos K; Hellard M; Pedrana A; Elliott J; Keen P; Costello J; Keane R; Kaldor J; Stoové M; Guy R, 2023, 'HIV treatment-as-prevention and its effect on incidence of HIV among cisgender gay, bisexual, and other men who have sex with men in Australia: a 10-year longitudinal cohort study', The Lancet HIV, http://dx.doi.org/10.1016/s2352-3018(23)00050-4
2023
Casten M; Herbert S; Smith DJ; Petoumenos K; Coorey C; Edmiston N, 2023, 'What are the predictors of change in multimorbidity among people with HIV? A longitudinal observational cohort study', HIV Medicine, 24, pp. 807 - 817, http://dx.doi.org/10.1111/hiv.13483
2023
King JM; Petoumenos K; Dobbins T; Guy RJ; Gray RT; Nigro SJ; Si D; Minas B; McGregor S, 2023, 'A population-level application of a method for estimating the timing of HIV acquisition among migrants to Australia', Journal of the International AIDS Society, 26, http://dx.doi.org/10.1002/jia2.26127
2023
Byonanebye DM; Polizzotto MN; Parkes-Ratanshi R; Musaazi J; Petoumenos K; Castelnuovo B, 2023, 'Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0282001
2023
Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
2023
Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0289907
2023
Cheng Q; Cunningham EB; Shih S; Amin J; Bruneau J; Artenie AA; Powis J; Litwin AH; Cooper C; Dalgard O; Hellard M; Bruggmann P; Marks P; Lacombe K; Stedman C; Read P; Hajarizadeh B; Dunlop AJ; Conway B; Feld JJ; Dore GJ; Grebely J; Dore G; Crawford S; Swan T; Byrne J; Coordinating Centre—Amanda Erratt ML; Marks P; Shaw I; Siriragavan S; Quiene S; Petoumenos K; Schmid P; Castro E; Moriggia A; Daulouede JP; Fraser C; Feld J; Gane E; Matthews G; Kronborg I; Shaw D; Norton B; Thurnheer MC; Weltman M; Dillon J; Kessler S; Knapp C; Oprandi L; Messina P; Pantic M; Le Cam M; Maitre C; Andreassen J; Melkeraaen I; Tollefsen MM; Pagarigan H; Milne R; Mason K; Kaznowski D; Zou L; Bouchard R; Kotsoros B; Muir M; Milloy J; Oliver V; Noonan T; Sevehon A; Hazelwood S; Hall M; Hagenauer M; Liddle R; Ferguson C; Agyemang L; Patel H; Soloway I; Cerocchi O; Lacalamita M; Fragomeli V; Gilliver R; Lothian R; Cleary S; Johnston L; Middleton S; D'Amico R; McGovern B; Anderson J; Zhong Z; Keane F; Tatsch F; Brainard D; McHutchison J, 2023, 'Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs', Value in Health, 26, pp. 883 - 892, http://dx.doi.org/10.1016/j.jval.2022.12.016
2023
Álvarez H; Mocroft A; Ryom L; Neesgaard B; Edwards S; Svedhem V; Günthard HF; Zangerle R; Smith C; Castagna A; D'Arminio Monforte A; Wit F; Stecher M; Lehman C; Mussini C; Fontas E; González E; Wasmuth JC; Sönnerborg A; De Wit S; Chkhartishvili N; Stephan C; Petoumenos K; Jaschinski N; Vannappagari V; Gallant J; Young L; Volny Anne A; Greenberg L; Martín-Iguacel R; Poveda E; Llibre JM, 2023, 'Plasma Human Immunodeficiency Virus 1 RNA and CD4+T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes with Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study', Clinical Infectious Diseases, 77, pp. 593 - 605, http://dx.doi.org/10.1093/cid/ciad219
2023
Yapa HM; Dhlomo-Mphatswe W; Moshabela M; De Neve JW; Herbst C; Jiamsakul A; Petoumenos K; Post FA; Pillay D; Bärnighausen T; Wyke S, 2022, 'A Continuous Quality Improvement Intervention to Improve Antenatal HIV Care Testing in Rural South Africa: Evaluation of Implementation in a Real-World Setting', International Journal of Health Policy and Management, 11, pp. 610 - 628, http://dx.doi.org/10.34172/ijhpm.2020.178
2022
Yapa HM; Kim HY; Petoumenos K; Post FA; Jiamsakul A; De Neve JW; Tanser F; Iwuji C; Baisley K; Shahmanesh M; Pillay D; Siedner MJ; Barnighausen T; Bor J, 2022, 'CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis', Clinical Infectious Diseases, 74, pp. 1350 - 1359, http://dx.doi.org/10.1093/cid/ciab650
2022
Rasmussen TA; Ahuja SK; Kuwanda L; Vjecha MJ; Hudson F; Lal L; Rhodes A; Chang J; Palmer S; Auberson-Munderi P; Mugerwa H; Wood R; Badal-Faesen S; Pillay S; Mngqibisa R; Larosa A; Hildago J; Petoumenos K; Chiu C; Lutaakome J; Kitonsa J; Kabaswaga E; Pala P; Ganoza C; Fisher K; Chang C; Lewin SR; Wright EJ, 2022, 'Antiretroviral Initiation at ≥800 CD4+ Cells/mm3Associated with Lower Human Immunodeficiency Virus Reservoir Size', Clinical Infectious Diseases, 75, pp. 1781 - 1791, http://dx.doi.org/10.1093/cid/ciac249
2022
MacHalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J, 2022, 'Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: Study protocol and rationale for a pragmatic before-after design', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-059968
2022
Herbert S; Puhr R; Petoumenos K; Lewis DA; Varma R; Couldwell DL; Law M; Templeton DJ, 2022, 'Characteristics of heterosexually-acquired compared to homosexually-acquired HIV and implications for clinical practice: results from the Australian HIV Observational Database', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 34, pp. 626 - 632, http://dx.doi.org/10.1080/09540121.2021.1884181
2022
Byonanebye DM; Polizzotto MN; Neesgaard B; Sarcletti M; Matulionyte R; Braun DL; Castagna A; de Wit S; Wit F; Fontas E; Vehreschild J; Vesterbacka J; Greenberg L; Hatleberg C; Garges H; Gallant J; Volny Anne A; Öllinger A; Mozer-Lisewska I; Surial B; Spagnuolo V; Necsoi C; van der Valk M; Mocroft A; Law M; Ryom L; Petoumenos K; Hillebregt M; Rose N; Hutchinson J; Zangerle R; Appoyer H; Delforge M; Stephan C; Bucht M; Chkhartishvili N; Chokoshvili O; Mussini C; Borghi V; Pradier C; Dollet K; Caissotti C; Casabona J; Miro JM; Smith C; Lampe F; Johnson M; Burns F; Chaloner C; Lazzarin A; Poli A; Sönnerborg A; Falconer K; Svedhem V; Günthard H; Ledergerber B; Bucher H; Scherrer A; Wasmuth JC; Rockstroh J; Fätkenheuer G; Stecher M; Schulze N; Franke B; Rooney J; McNicholl I; Vannappagari V; Wandeler G; Lundgren J; Kowalska J; Raben D; Mocroft A; Peters L; Williams ED; D’Arminio Monforte A; Bruguera A; Dedes N; Mendao L; Larsen JF; Jaschinski N; Jakobsen ML; Bruun T; Bojesen A; Hansen EV; Traytel AK; Elsing TW; Kristensen D; Weide T; Bansi-Matharu L; Pelchen-Matthews A, 2022, 'Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium', HIV Medicine, 23, pp. 895 - 910, http://dx.doi.org/10.1111/hiv.13273
2022
Greenberg L; Ryom L; Neesgaard B; Miró JM; Dahlerup Rasmussen L; Zangerle R; Grabmeier-Pfistershammer K; Günthard HF; Kusejko K; Smith C; Mussini C; Menozzi M; Wit F; Van Der Valk M; D'Arminio Monforte A; De Wit SDS; Necsoi C; Pelchen-Matthews A; Lundgren J; Peters L; Castagna A; Muccini C; Vehreschild JJ; Pradier C; Bruguera Riera A; Sönnerborg A; Petoumenos K; Garges H; Rogatto F; Dedes N; Bansi-Matharu L; Mocroft A, 2022, 'Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting', Open Forum Infectious Diseases, 9, http://dx.doi.org/10.1093/ofid/ofac029
2022
Boettiger DC; Huque MH; Bloch M; Woolley I; Templeton DJ; Law MG; Fraser N; Hoy J; Petoumenos K; Law M, 2022, 'Physical function limitation among gay and bisexual men aged ≥55years with and without HIV: findings from the Australian Positive and Peers Longevity Evaluation Study (APPLES)', Sexual Health, 19, pp. 533 - 545, http://dx.doi.org/10.1071/sh22085
2022
Borges ÁH; Lundh A; Tendal B; Bartlett JA; Clumeck N; Costagliola D; Daar ES; Echeverría P; Gisslén M; Huedo-Medina TB; Hughes MD; Hullsiek KH; Khabo P; Komati S; Kumar P; Lockman S; MacArthur RD; Maggiolo F; Matteelli A; Miro JM; Oka S; Petoumenos K; Puls RL; Riddler SA; Sax PE; Sierra-Madero J; Torti C; Lundgren JD, 2021, 'Nonnucleoside reverse-transcriptase inhibitor- vs ritonavir-boosted protease inhibitor-based regimens for initial treatment of HIV Infection: A systematic review and metaanalysis of randomized trials', Clinical Infectious Diseases, 63, pp. 268 - 280, http://dx.doi.org/10.1093/cid/ciw236
2021
Dharan NJ; Yeh P; Bloch M; Yeung MM; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy JF; Woolley I; Pell C; Templeton DJ; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson SJ; Polizzotto MN; Dawson MA; Vincent T; Rosario R; Lau H; Smith D; Price S; O’Brien J; Tan HTL; Sinclair B; Bascombe F, 2021, 'HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults', Nature Medicine, 27, pp. 1006 - 1011, http://dx.doi.org/10.1038/s41591-021-01357-y
2021
Byonanebye DM; Polizzotto MN; Begovac J; Grabmeier-Pfistershammer K; Abela I; Castagna A; de Wit S; Mussini C; Vehreschild JJ; d'Arminio Monforte A; Wit FWNM; Pradier C; Chkhartishvili N; Sönnerborg A; Hoy J; Lundgren J; Neesgaard B; Bansi-Matharu L; Greenberg L; Llibre JM; Vannappagari V; Gallant J; Necsoi C; Cichon P; Reiss P; Aho I; Tsertsvadze T; Mennozzi M; Rauch A; Muccini C; Law M; Mocroft A; Ryom L; Petoumenos K; Hillebregt M; Rose N; Zangerle R; Appoyer H; Delforge M; Wandeler G; Stephan C; Bucht M; Chokoshvili O; Rodano A; Tavelli A; Fanti I; Borghi V; Fontas E; Dollet K; Caissotti C; Casabona J; Miro JM; Smith C; Lampe F; Johnson M; Burns F; Chaloner C; Lazzarin A; Poli A; Falconer K; Svedhem V; Günthard H; Ledergerber B; Bucher H; Scherrer A; Wasmuth JC; Rockstroh J; Fätkenheuer G; Stecher M; Schulze N; Franke B; Rooney J; Rogatto F; Garges H; Kowalska J; Raben D; Peters L; Anne AV; Dedes N; Williams ED; Bruguera A; Haubrich R; Svedhem-Johansson V; Bloch M; Braun D; Calmy A; Schüttfort G; Youle M; Zona S; Antinori A; Bolokadze N; Schwarze-Zander C; Duvivier C; Dragovic G; Radoi R; Oprea C; Vasylyev M; Matulionyte R; Mulabdic V; Marchetti G, 2021, 'Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents', AIDS, 35, pp. 869 - 882, http://dx.doi.org/10.1097/QAD.0000000000002811
2021
Matthews GV; Bhagani S; Van der Valk M; Rockstroh J; Feld JJ; Rauch A; Thurnheer C; Bruneau J; Kim A; Hellard M; Shaw D; Gane E; Nelson M; Ingiliz P; Applegate TL; Grebely J; Marks P; Martinello M; Petoumenos K; Dore GJ; Marks P; Feld J; Amjad S; Tu E; Tamaddoni M; Thurnheer MC; Gilleece Y; Fraser C; Moriggia A; Lutz T; Moon J; Read P; Ustianowski A; Cordes C; Sasadeusz J; Hull M; Braun D, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056
2021
McManus H; Callander D; Asselin J; McMahon J; Hoy JF; Templeton DJ; Fairley CK; Donovan B; Pedrana AE; Keen P; Wilson DP; Elliott J; Kaldor J; Liaw ST; Petoumenos K; Holt M; Hellard ME; Grulich AE; Carr A; Stoove MA; Guy RJ, 2021, 'A New Method for Estimating the Incidence of Infectious Diseases', American Journal of Epidemiology, 190, pp. 1386 - 1395, http://dx.doi.org/10.1093/aje/kwab014
2021
Petoumenos K; Kuwanda L; Ryom L; Mocroft A; Reiss P; De Wit S; Pradier C; Bonnet F; Phillips A; Hatleberg CI; D'Arminio Monforte A; Weber R; Sabin CA; Lundgren J; Law MG, 2021, 'Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results from the D:A:D Study', Journal of Acquired Immune Deficiency Syndromes, 86, pp. 579 - 586, http://dx.doi.org/10.1097/QAI.0000000000002603
2021
Chammartin F; Lodi S; Logan R; Ryom L; Mocroft A; Kirk O; D'Arminio Monforte A; Reiss P; Phillips A; El-Sadr W; Hatleberg CI; Pradier C; Bonnet F; Law M; De Wit S; Sabin C; Lundgren JD; Bucher HC; Calvo G; Dabis F; Morfeldt L; Weber R; Lind-Thomsen A; Salbøl Brandt R; Hillebreght M; Zaheri S; Wit FWNM; Scherrer A; Schoni-Affolter F; Rickenbach M; Tavelli A; Fanti I; Leleux O; Mourali J; Le Marec F; Boerg E; Thulin E; Sundstrom A; Bartsch G; Thompsen G; Necsoi C; Delforge M; Fontas E; Caissotti C; Dollet K; Mateu S; Torres F; Petoumenos K; Blance A; Huang R; Puhr R; Grønborg Laut K; Kristensen D; Kamara DA; Smith CJ; Raben D; Matthews C; Bojesen A; Grevsen AL; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Smit C; Ross M; Fux CA; Morlat P; Friis-Møller N; Kowalska J; Bohlius J; Bower M; Fatkenheuer G; Grulich A; Sjøl A; Meidahl P; Iversen JS; Hillebregt M; Prins JM; Kuijpers TW; Scherpbier HJ; Van Der Meer JTM; Godfried MH; Van Der Poll T; Nellen FJB; Geerlings SE; Van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; Van Der Valk M; Goorhuis A; Hovius JW; Van Eden J; Henderiks A; Van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Jurriaans S; Back NKT, 2021, 'Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study', Annals of Internal Medicine, 174, pp. 768 - 776, http://dx.doi.org/10.7326/M20-5226
2021
van Santen DK; Asselin J; Haber NA; Traeger MW; Callander D; Donovan B; El-Hayek C; McMahon JH; Petoumenos K; McManus H; Hoy JF; Hellard M; Guy R; Stoové M; Carr A; Elliot J; Templeton DJ; Liaw T; Wilson DP, 2021, 'Improvements in transition times through the HIV cascade of care among gay and bisexual men with a new HIV diagnosis in New South Wales and Victoria, Australia (2012–19): a longitudinal cohort study', The Lancet HIV, 8, pp. e623 - e632, http://dx.doi.org/10.1016/S2352-3018(21)00155-7
2021
Goddard SL; Poynten IM; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Templeton DJ, 2021, 'Self-reported anal symptoms and their association with anal pathology among gay and bisexual men: A cross-sectional observational analysis', Sexual Health, 18, pp. 123 - 129, http://dx.doi.org/10.1071/SH20104
2021
Pinto A; Carrera A; Salem H; Thapa K; Shaik A; Petoumenos K; Cunningham P; Garsia R; Dwyer D; Cooper DA; Kelleher A, 2021, 'Evolution of HIV-1 Surveillance Drug Resistance Mutations over 10 Years in New South Wales, Australia', AIDS Research and Human Retroviruses, 37, pp. 897 - 902, http://dx.doi.org/10.1089/aid.2016.0301
2021
Greenberg L; Ryom L; Neesgaard B; Wandeler G; Staub T; Gisinger M; Skoll M; Günthard HF; Scherrer A; Mussini C; Smith C; Johnson M; De Wit S; Necsoi C; Pradier C; Wit F; Lehmann C; D'Arminio Monforte A; Miró JM; Castagna A; Spagnuolo V; Sönnerborg A; Law M; Hutchinson J; Chkhartishvili N; Bolokadze N; Wasmuth JC; Stephan C; Vannappagari V; Rogatto F; Llibre JM; Duvivier C; Hoy J; Bloch M; Bucher HC; Calmy A; Volny Anne A; Pelchen-Matthews A; Lundgren JD; Peters L; Bansi-Matharu L; Mocroft A; Reiss P; Hillebregt M; Petoumenos K; Rose N; Zangerle R; Appoyer H; De Wit S; Delforge M; Bucht M; Chokoshvili O; Rodano A; Tavelli A; Fanti I; Borghi V; Fontas E; Dollet K; Caissotti C; Casabona J; Miro JM; Riera A; Reyes-Urueña J; Lampe F; Lazzarin A; Poli A; Falconer K; Svedhem V; Ledergerber B; Bucher H; Rockstroh J; Vehreschild JJ; Fätkenheuer G; Mocroft A; Rooney J; Vannappagari V; Garges H; Law M; Zangerle R; Smith C; De Wit S; Lundgren J; Günthard H; Lundgren J, 2021, 'Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living with Human Immunodeficiency Virus', Clinical Infectious Diseases, 73, pp. E2323 - E2333, http://dx.doi.org/10.1093/cid/ciaa1878
2021
Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS; Kaldor J; McNulty A; Lewis DA; Chen MY; Bilardi JE; Tabrizi SN; Murray GL; Danielewski J; Garland SM; McNamee K; Han A, 2020, 'Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence', BMC Infectious Diseases, 20, pp. 834, http://dx.doi.org/10.1186/s12879-020-05563-w
2020
Huang R; Liu N; Nicdao MA; Mikaheal M; Baldacchino T; Albeos A; Petoumenos K; Sud K; Kim J, 2020, 'Emotion sharing in remote patient monitoring of patients with chronic kidney disease', Journal of the American Medical Informatics Association, 27, pp. 185 - 193, http://dx.doi.org/10.1093/jamia/ocz183
2020
Neesgaard B; Mocroft A; Zangerle R; Wit F; Lampe F; Günthard HF; Necsoi C; Law M; Mussini C; Castagna A; Monforte ADA; Pradier C; Chkhartisvilli N; Reyes-Uruena J; Vehreschild JJ; Wasmuth JC; Sönnerborg A; Stephan C; Greenberg L; Llibre JM; Volny-Anne A; Peters L; Pelchen-Matthews A; Vannappagari V; Gallant J; Rieger A; Youle M; Braun D; de Wit S; Petoumenos K; Borghi V; Spagnuolo V; Tsertsvadze T; Lundgren J, 2020, 'Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0243625
2020
Mocroft A; Neesgard B; Zangerle R; Rieger A; Castagna A; Spagnuolo V; Antinori A; Lampe FC; Youle M; Vehreschild JJ; Mussini C; Borghi V; Begovac J; Duvivier C; Gunthard HF; Rauch A; Tiraboschi J; Chkhartishvili N; Bolokadze N; Wit F; Wasmuth JC; De Wit S; Necsoi C; Pradier C; Svedhem V; Stephan C; Petoumenos K; Garges H; Rogatto F; Peters L; Ryom L, 2020, 'Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment', HIV Medicine, 21, pp. 599 - 606, http://dx.doi.org/10.1111/hiv.12888
2020
Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM; Farnsworth A; Biro C; Richards A; Thurloe J; Ekman D; McDonald R; Adams M; Tabrizi S; Phillips S; Luque MM; Comben S; McCaffery K; Howard K; Kelly P; Seeds D; Carr A; Feeney L; Gluyas R; Prestage G; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P; Varma R; Langton-Lockton J; Tong W; Han A, 2020, 'Prevalence and association of perianal and intra-anal warts with composite high-grade squamous intraepithelial lesions among gay and bisexual men: Baseline data from the study of the prevention of anal cancer', AIDS Patient Care and STDs, 34, pp. 436 - 443, http://dx.doi.org/10.1089/apc.2020.0067
2020
Martinello M; Orkin C; Cooke G; Bhagani S; Gane E; Kulasegaram R; Shaw D; Tu E; Petoumenos K; Marks P; Grebely J; Dore GJ; Nelson M; Matthews GV, 2020, 'Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection', Hepatology, 72, pp. 7 - 18, http://dx.doi.org/10.1002/hep.31003
2020
Dharan NJ; Radovich T; Che S; Petoumenos K; Juneja P; Law M; Huang R; McManus H; Polizzotto MN; Guy R; Cronin P; Cooper DA; Gray RT, 2020, 'Comorbidity Medications Are Dispensed to More People Receiving Antiretroviral Therapy for HIV Compared with the General Population in Australia', AIDS Research and Human Retroviruses, 36, pp. 291 - 296, http://dx.doi.org/10.1089/aid.2019.0117
2020
Hutchinson JL; Lewis DA; Law M; Bavinton BR; Puhr R; Petoumenos K; Han A, 2020, 'Clinical characteristics of overseas-born men who have sex with men (MSM) in the AHOD cohort and implications for clinical practice', Sexually Transmitted Infections, 96, pp. 469 - 470, http://dx.doi.org/10.1136/sextrans-2019-054364
2020
Dore GJ; Feld JJ; Thompson A; Martinello M; Muir AJ; Agarwal K; Müllhaupt B; Wedemeyer H; Lacombe K; Matthews GV; Schultz M; Klein M; Hezode C; Mercade GE; Kho D; Petoumenos K; Marks P; Tatsch F; Dos Santos AGP; Gane E, 2020, 'Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial', Journal of Hepatology, 72, pp. 431 - 440, http://dx.doi.org/10.1016/j.jhep.2019.10.010
2020
Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV, 2020, 'Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV', AIDS, 34, pp. 1347 - 1358, http://dx.doi.org/10.1097/QAD.0000000000002562
2020
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985
2020
Wit F; Reiss P; Hillebregt M; Law M; Petoumenos K; Rose N; Hutchinson J; Zangerle R; Appoyer H; De Wit S; Delforge M; Wandeler G; Stephan C; Bucht M; Chkhartishvili N; Chokoshvili O; D’Arminio Monforte A; Rodano A; Tavelli A; Fanti I; Mussini C; Borghi V; Pradier C; Fontas E; Dollet K; Caissotti C; Casabona J; Miro JM; Riera A; Reyes-Urueña J, 2020, 'How to RESPOND to modern challenges for people living with HIV: A profile for a new cohort consortium', Microorganisms, 8, pp. 1 - 17, http://dx.doi.org/10.3390/microorganisms8081164
2020
Yapa HM; Drayne R; Klein N; De Neve JW; Petoumenos K; Jiamsakul A; Herbst C; Pillay D; Post FA; Bärnighausen T, 2020, 'Infant feeding knowledge and practice vary by maternal HIV status: A nested cohort study in rural South Africa', International Breastfeeding Journal, 15, http://dx.doi.org/10.1186/s13006-020-00317-5
2020
McManus H; Callander D; Donovan B; Russell DB; O'Connor CC; Davies SC; Lewis DA; Hellard ME; Chen MY; Petoumenos K; Varma R; Cogle A; Boyd MA; Grulich A; Pollard J; Medland N; Fairley CK; Guy RJ, 2019, 'Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015', Medical Journal of Australia, 210, pp. 269 - 275, http://dx.doi.org/10.5694/mja2.50006
2019
Shepherd L; Ryom L; Law M; Petoumenos K; Hatleberg CI; D'Arminio Monforte A; Sabin C; Bower M; Bonnet F; Reiss P; De Wit S; Pradier C; Weber R; El-Sadr W; Lundgren J; Mocroft A, 2019, 'Cessation of cigarette smoking and the impact on cancer incidence in human immunodeficiency virus-infected persons: The data collection on adverse events of anti-HIV drugs study', Clinical Infectious Diseases, 68, pp. 650 - 657, http://dx.doi.org/10.1093/cid/ciy508
2019
Dharan NJ; Radovich T; Che S; Petoumenos K; Juneja P; Law M; Huang R; McManus H; Polizzotto MN; Guy R; Cronin P; Cooper DA; Gray RT; Law M; Han A, 2019, 'HIV treatment regimens and adherence to national guidelines in Australia: An analysis of dispensing data from the Australian pharmaceutical benefits scheme', BMC Public Health, 19, pp. 13, http://dx.doi.org/10.1186/s12889-018-6325-5
2019
Goddard SL; Templeton DJ; Petoumenos K; Jin F; Hillman RJ; Law C; Roberts JM; Fairley CK; Garland SM; Grulich AE; Poynten IM; Prestage G; Tong W; Carr A; Varma R, 2019, 'Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC)', Cancer Epidemiology, 58, pp. 12 - 16, http://dx.doi.org/10.1016/j.canep.2018.10.009
2019
Dore G; Feld J; Thompson A; Martinello M; Muir A; Agarwal K; Mullhaupt B; Wedemeyer H; Lacombe K; Matthews G; Schultz M; Mercade GE; Kho D; Filep E; Petoumenos K; Marks P; Tatsch F; dos Santos AGP; Gane E, 2019, 'Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir: the SMART-C study', JOURNAL OF HEPATOLOGY, 70, pp. E110 - E110, http://dx.doi.org/10.1016/S0618-8278(19)30196-3
2019
Martinello M; Orkin C; Cooke G; Bhagani S; Gane E; Kulasegaram R; Shaw D; Tu E; Filep E; Petoumenos K; Marks P; Applegate T; Grebely J; Dore G; Nelson M; Matthews G, 2019, 'Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection', JOURNAL OF HEPATOLOGY, 70, pp. E231 - E231, http://dx.doi.org/10.1016/S0618-8278(19)30432-3
2019
Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9
2019
Puhr R; Petoumenos K; Huang R; Templeton DJ; Woolley I; Bloch M; Russell D; Law MG; Cooper DA, 2019, 'Cardiovascular disease and diabetes in HIV-positive and HIV-negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study', HIV Medicine, 20, pp. 121 - 130, http://dx.doi.org/10.1111/hiv.12689
2019
Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K, 2018, 'Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality', AIDS Research and Human Retroviruses, 34, pp. 936 - 941, http://dx.doi.org/10.1089/aid.2017.0284
2018
Edmiston N; Petoumenos K; Smith DJ, 2018, 'Multimorbidity, not human immunodeficiency virus (HIV) markers predicts unplanned admission among people with HIV in regional New South Wales', Internal Medicine Journal, 48, pp. 706 - 713, http://dx.doi.org/10.1111/imj.13733
2018
Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM, 2018, 'Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database', Nephrology, 23, pp. 778 - 786, http://dx.doi.org/10.1111/nep.13100
2018
McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years', AIDS, 32, pp. 451 - 459, http://dx.doi.org/10.1097/QAD.0000000000001709
2018
Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD, 2018, 'RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency', Retrovirology, 15, pp. 67, http://dx.doi.org/10.1186/s12977-018-0451-0
2018
Huang R; Petoumenos K; Gray RT; McManus H; Dharan N; Guy R; Cooper DA, 2018, 'National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohort', Journal of Clinical Epidemiology, 100, pp. 82 - 91, http://dx.doi.org/10.1016/j.jclinepi.2018.04.015
2018
Gray RT; Watson J; Cogle AJ; Smith DE; Hoy JF; Bastian LA; Finlayson R; Drummond FM; Whittaker B; Law MG; Petoumenos K; Han A, 2018, 'Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive', Sexual Health, 15, pp. 13 - 19, http://dx.doi.org/10.1071/SH16237
2018
Hughes C; Puhr R; Ojaimi S; Petoumenos K; Bartlett AW; Templeton DJ; O'Connor CC; Gunathilake M; Woolley I, 2018, 'Human immunodeficiency virus-infected young people in Australia: data from the Australian HIV Observational Database', Internal Medicine Journal, 48, pp. 1447 - 1456, http://dx.doi.org/10.1111/imj.14040
2018
Grebely J; Conway B; Cunningham EB; Fraser C; Moriggia A; Gane E; Stedman C; Cooper C; Castro E; Schmid P; Petoumenos K; Hajarizadeh B; Marks P; Erratt A; Dalgard O; Lacombe K; Feld JJ; Bruneau J; Daulouede JP; Powis J; Bruggmann P; Matthews GV; Kronborg I; Shaw D; Dunlop A; Hellard M; Applegate TL; Crawford S; Dore GJ, 2018, 'Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy', International Journal of Drug Policy, 62, pp. 94 - 103, http://dx.doi.org/10.1016/j.drugpo.2018.10.004
2018
Martinello M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Grebely J; Nelson M; Matthews GV, 2018, 'Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection', Journal of Viral Hepatitis, 25, pp. 1180 - 1188, http://dx.doi.org/10.1111/jvh.12917
2018
Trevillyan JM; Wong G; Puls R; Petoumenos K; Emery S; Mellett NA; Mundra PA; Meikle PJ; Hoy JF, 2018, 'Changes in plasma lipidome following initiation of antiretroviral therapy', PLoS ONE, 13, pp. e0202944, http://dx.doi.org/10.1371/journal.pone.0202944
2018
McMahon CN; Petoumenos K; Hesse K; Carr A; Cooper DA; Samaras K, 2018, 'High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.', AIDS, 32, pp. 451 - 459, http://dx.doi.org/10.1097/QAD.0000000000001709
2018
Jin F; Roberts JM; Grulich AE; Poynten IM; MacHalek DA; Cornall A; Phillips S; Ekman D; McDonald RL; Hillman RJ; Templeton DJ; Farnsworth A; Garland SM; Fairley CK; Tabrizi SN; Law C; Biro C; Richards A; Thurloe J; Adams M; McCaffery K; Howard K; Kelly P; Seeds D; Garcia M; Carr A; Feeney L; Gluyas R; Prestage G; Petoumenos K; Law M; Acraman B; McGrath P; Mellor R; Pezzopane P, 2017, 'The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men', AIDS, 31, pp. 1303 - 1311, http://dx.doi.org/10.1097/QAD.0000000000001462
2017
Templeton DJ; Roberts JM; Poynten IM; Law C; Hillman RJ; Farnsworth A; Fairley CK; Tabrizi SN; Garland SM; Grulich AE; Jin F; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley K; Feeney L; Fraissard E; Howard K; Law M; MacHalek D; McCaffery K; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2017, 'Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC)', European Journal of Cancer Prevention, 26, pp. 212 - 216, http://dx.doi.org/10.1097/CEJ.0000000000000321
2017
Martinello M; Grebely J; Petoumenos K; Gane E; Hellard M; Shaw D; Sasadeusz J; Applegate TL; Dore GJ; Matthews GV, 2017, 'HCV reinfection incidence among individuals treated for recent infection', Journal of Viral Hepatitis, 24, pp. 359 - 370, http://dx.doi.org/10.1111/jvh.12666
2017
Petoumenos K; Choi JY; Hoy J; Kiertiburanakul S; Ng OT; Boyd M; Rajasuriar R; Law M; Han A, 2017, 'CD4:CD8 ratio comparison between cohorts of HIV-positive Asians and Caucasians upon commencement of antiretroviral therapy', Antiviral Therapy, 22, pp. 659 - 668, http://dx.doi.org/10.3851/IMP3155
2017
Petoumenos K; Huang R; Hoy J; Bloch M; Templeton DJ; Baker D; Giles M; Law MG; Cooper DA; Han A, 2017, 'Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years - The Australian Positive & Peers Longevity Evaluation Study (APPLES)', PLoS ONE, 12, pp. e0184583, http://dx.doi.org/10.1371/journal.pone.0184583
2017
Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504
2017
Roberts JM; Jin F; Thurloe JK; Ekman D; Adams MK; McDonald RL; Biro C; Poynten IM; Grulich AE; Farnsworth A; Aarnsworth R; Acraman B; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Fairley C; Farnsworth A; Feeney L; Garcia M; Garland S; Gluyas R; Hillman R; Howard K; Lawa F; Law C; Law M; Machalek D; McCaffery K; McGrath P; Mellor R; Pendlebury S; Petoumenos K; Pezzopane P; Phillips S; Mary Poynten I; Prestage G; Richards A; Seeds D; Segelov E; Tabrizi S; Templeton D; Tong W; Varma R, 2016, 'The value of a transformation zone component in anal cytology to detect HSIL', Cancer Cytopathology, 124, pp. 596 - 601, http://dx.doi.org/10.1002/cncy.21730
2016
Petoumenos K; Law MG, 2016, 'Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons', Current Opinion in HIV and AIDS, 11, pp. 514 - 520, http://dx.doi.org/10.1097/COH.0000000000000306
2016
Giles ML; Zapata MC; Wright ST; Petoumenos K; Grotowski M; Broom J; Law MG; O'Connor CC, 2016, 'How do outcomes compare between women and men living with HIV in Australia? An observational study', Sexual Health, 13, pp. 155 - 161, http://dx.doi.org/10.1071/SH15124
2016
Machalek DA; Jin F; Poynten IM; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men', Papillomavirus Research, 2, pp. 97 - 105, http://dx.doi.org/10.1016/j.pvr.2016.05.003
2016
Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', ANTIVIRAL THERAPY, 21, pp. 425 - 434, http://dx.doi.org/10.3851/IMP3035
2016
Moore CL; Gidding HF; Jin F; Mao L; Petoumenos K; Zablotska IB; Poynten IM; Prestage G; Law MG; Grulich AE; Amin J; Han A, 2016, 'Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men', AIDS and Behavior, 20, pp. 2372 - 2386, http://dx.doi.org/10.1007/s10461-016-1303-3
2016
Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Mao L; Petoumenos K; Zablotska IB; Poynten IM; Law MG; Amin J; Han A, 2016, 'Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men', HIV Medicine, 17, pp. 327 - 339, http://dx.doi.org/10.1111/hiv.12312
2016
Machalek DA; Poynten IM; Jin F; Hillman RJ; Templeton DJ; Law C; Roberts JM; Tabrizi SN; Garland SM; Farnsworth A; Fairley CK; Grulich AE; Acraman B; Adams M; Carr A; Carroll S; Cooper D; Cornall A; Crampton L; Ekman D; Fairley K; Feeney L; Fraissard E; Howard K; Law M; McCaffery K; McDonald R; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Tong W; Varma R, 2016, 'A composite cytology-histology endpoint allows a more accurate estimate of anal high-grade squamous intraepithelial lesion prevalence', Cancer Epidemiology Biomarkers and Prevention, 25, pp. 1134 - 1143, http://dx.doi.org/10.1158/1055-9965.EPI-15-1106
2016
Mulhall BP; Wright ST; De La Mata N; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Foster R; Read T; Russell D; Smith DJ; Templeton DJ; Fairley CK; Law MG, 2016, 'Risk factors associated with incident sexually transmitted infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study', HIV Medicine, 17, pp. 623 - 630, http://dx.doi.org/10.1111/hiv.12371
2016
Callander D; Stoové M; Carr A; Hoy JF; Petoumenos K; Hellard M; Elliot J; Templeton DJ; Liaw S; Wilson DP; Grulich A; Cooper DA; Pedrana A; Donovan B; McMahon J; Prestage G; Holt M; Fairley CK; McKellar-Stewart N; Ruth S; Asselin J; Keen P; Cooper C; Allan B; Kaldor JM; Guy R; Cooper D; Liaw T, 2016, 'A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: The Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocol', BMC Infectious Diseases, 16, pp. 752, http://dx.doi.org/10.1186/s12879-016-2073-2
2016
Martinello M; Gane E; Hellard M; Sasadeusz J; Shaw D; Petoumenos K; Applegate T; Grebely J; Maire L; Marks P; Dore GJ; Matthews GV; Cooper D, 2016, 'Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study', Hepatology, 64, pp. 1911 - 1921, http://dx.doi.org/10.1002/hep.28844
2016
Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2016, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies', Antiviral therapy, 21, pp. 465, http://dx.doi.org/10.3851/IMP3073
2016
Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Petoumenos K; Zablotska IB; Poynten IM; Mao L; Law MG; Amin J; Han A, 2016, 'Hospitalization for anxiety and mood disorders in HIV-infected and -uninfected gay and bisexual men', Journal of Acquired Immune Deficiency Syndromes, 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147
2016
Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Petoumenos K; Zablotska IB; Poynten IM; Mao L; Law MG; Amin J, 2016, 'Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.', J Acquir Immune Defic Syndr, 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147
2016
Kovari H; Sabin CA; Ledergerber B; Ryom L; Reiss P; Law M; Pradier C; Dabis F; d'Arminio Monforte A; Smith C; de Wit S; Kirk O; Lundgren JD; Weber R, 2016, 'Antiretroviral drugs and risk of chronic alanine aminotransferase elevation in human immunodeficiency virus (HIV)-monoinfected persons: The data collection on adverse events of Anti-HIV drugs study', Open Forum Infectious Diseases, 3, http://dx.doi.org/10.1093/ofid/ofw009
2016
Boyd MA; Donovan B; Prestage G; Chen M; Petoumenos K; Gray R; Guy R; Rogers GB; Bourne C; Klausner JD, 2015, 'Is it time to rethink syphilis control?', Clinical Infectious Diseases, 60, pp. 325 - 326, http://dx.doi.org/10.1093/cid/ciu813
2015
Edmiston N; Passmore E; Smith DJ; Petoumenos K, 2015, 'Multimorbidity among people with HIV in regional New South Wales, Australia', Sexual Health, 12, pp. 425 - 432, http://dx.doi.org/10.1071/SH14070
2015
Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Sabin CA; Phillips A; Weber R; Pradier C; d'Arminio Monforte A; Dabis F; El-Sadr WM; De Wit S; Kamara D; Tverland J; Mansfeld M; Nielsen J; Raben D; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Kesselring AM; Friis-Møller N; Kowalska J; Sabin C; Bruyand M; Kamara DA; Bower M; Fätkenheuer G; Donald A; Grulich A; Prins JM; Kuijpers TW; Scherpbier HJ; van der Meer JTM; Wit FWMN; Godfried MH; van der Poll T; Nellen FJB; Geerlings SE; van Vugt M; Pajkrt D; Bos JC; Wiersinga WJ; van der Valk M; Goorhuis A; Hovius JW; van Eden J; Henderiks A; van Hes AMH; Mutschelknauss M; Nobel HE; Pijnappel FJJ; Westerman AM; Jurriaans S; Back NKT; Zaaijer HL; Berkhout B; Cornelissen MTE; Schinkel CJ; Thomas XV; van den Berge M; Stegeman A; Baas S; Hage de Looff L; Versteeg D; Pronk MJH; Ammerlaan HSM; Korsten-Vorstermans EMHM; de Munnik ES; Jansz AR; Tjhie J; Finlayson R; Cooper D; Carr A; Bloch M; Harrod M; Pett S; Petoumenos K; Gold J; Medland N; Sullivan J; Han A, 2015, 'Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study', PLoS Medicine, 12, pp. e1001809, http://dx.doi.org/10.1371/journal.pmed.1001809
2015
Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Little JL; Smith D; Mincham C; Baker D; Ieroklis V; Templeton DJ; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Taylor S; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Patel A; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Fernando S; Chuah J; Watson J; Lawrence C; Mulhall B; McManus H; Bendall C; Boyd M; Ryder N; Payne R; Russell D; Doyle-Adams S; Sowden D; Taing K; McGill K; Orth D; Youds D; Gibson A; Magon H; Dickson B; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Giles M; Hoy J; Williams J; Nolan D; Robinson J; Morwood K; Roth N; Choong K; Li PCK; Lee MP; Vanar S; Faridah S; Kamarulzaman A; Choi JY; Vannary B; Ditangco R; Tsukada K; Pujari S; Makane A; Ng OT; Sasisopin AJ; Han A, 2015, 'Temporal trends of time to antiretroviral treatment initiation, interruption and modification: Examination of patients diagnosed with advanced HIV in Australia', Journal of the International AIDS Society, 18, pp. 19463, http://dx.doi.org/10.7448/IAS.18.1.19463
2015
McManus H; Petoumenos K; Brown K; Baker D; Russell D; Read T; Smith D; Wray L; Giles M; Hoy J; Carr A; Law MG; Australian HIV Observational Database , 2015, 'Loss to follow-up in the Australian HIV Observational Database', Antiviral Therapy, 20, pp. 731 - 741, http://dx.doi.org/10.3851/IMP2916
2015
Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA; Belloso W; Gazzard B; Hung CC; Jessen H; Kamrulazaman A; Li L; Losso M; Sierra-Madero J; Mallon P; Mason B; Molina JM; Petoumenos K; Phanuphak P; Pollack S; Rooney J; Walmsley S; Wolff M, 2015, 'Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART', PLoS ONE, 10, pp. e0118608, http://dx.doi.org/10.1371/journal.pone.0118608
2015
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P; Acraman B, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003
2015
Petoumenos K; Law M; Han A, 2015, 'HIV-infection and comorbidities: A complex mix', The Lancet HIV, 2, pp. e265 - e266, http://dx.doi.org/10.1016/S2352-3018(15)00082-X
2015
Tong WWY; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A; Acraman B; Fraissard E; Law C; McGrath P; Mellor R; Norris R; O'Dwyer M; Seeds D; Thompson K; Varma R; Adams M; Biro C; Cornall A; Crampton L; Ekman D; Ellard J; Farnsworth A; Feeney L; Howard K; Hyne S; Law M; Machalek D; McCaffery K; McDonald R; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Roberts J; Schema L; Segelov E; Tabrizi S; Thurloe J; Bailey M; Cunningham P; Fsadni B; Grassi K; Ip S; Lograsso M; McBride K; Merlin K; Munier M-L; Piperias M; Xu Y, 2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions', Journal of Infectious Diseases, 211, pp. 405 - 415, http://dx.doi.org/10.1093/infdis/jiu461
2015
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG; Han A, 2015, 'Recent trends in early stage response to combination antiretroviral therapy in Australia', Antiviral Therapy, 20, pp. 131 - 139, http://dx.doi.org/10.3851/IMP2774
2015
McManus H; Hoy JF; Woolley I; Boyd MA; Kelly MD; Mulhall B; Roth NJ; Petoumenos K; Law MG, 2015, 'Erratum: Recent trends in early stage response to combination antiretroviral therapy in Australia', Antiviral Therapy, 20, pp. 255, http://dx.doi.org/10.3851/IMP2822
2015
De La Mata N; Mao L; De Wit J; Smith D; Holt M; Prestage G; Wilson DP; Petoumenos K, 2015, 'Estimating antiretroviral treatment coverage rates and viral suppression rates for homosexual men in Australia', Sexual Health, 12, pp. 453 - 457, http://dx.doi.org/10.1071/SH15037
2015
Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; Ellis D; Bloch M; Franic T; Agrawal S; McCann L; Cunningham N; Vincent T; Allen D; Little JL; Smith D; Gray C; Baker D; Vale R; Templeton DJ; Dijanosic C; Jackson E; McCallum K; Taylor S; Cooper D; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Shakeshaft J; Brown K; McGrath C; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Watson J; Lawrence C; Mulhall B; Law M; Petoumenos K; McManus H; Bendall C; Boyd M; Kulatunga A; Knibbs P; Chuah J; Ngieng M; Dickson B; Russell D; Downing S; Sowden D; Broom J; Taing K; Johnston C; McGill K; Orth D; Youds D; Kelly M; Gibson A; Magon H; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Nicolson J; Lau H; Read T; Silvers J; Zeng W; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Skett J; Robinson J; Mean CV; Saphonn V; Vohith K; Zhang FJ; Li PCK; Lee MP; Kumarasamy N; Saghayam S; Ezhilarasi C; Pujari S, 2015, 'HIV and aging: Insights from the Asia Pacific HIV Observational Database (APHOD)', HIV Medicine, 16, pp. 152 - 160, http://dx.doi.org/10.1111/hiv.12188
2015
Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Allardice K; Baker D; Odgers E; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Ryder N; Taylor S; Cooper D; Carr A; Lee F; McRae K; Hesse K; Finlayson R; Gupta S; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Arvela N; Wray L; Thng C; Foster R; Lu H; Couldwell D; DSmith E; Furner V; Fernando S; Dubbo ; Watson J; Mulhall B; Wright S; Bendall C; Boyd M; Gunathilake M; Payne R; O'Sullivan M; White S; Russell D; Joslin J; Cashman C; Sowden D; Taing K; McGill K; Orth D; Youds D; Kelly M; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; NRoth J; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K; Morwood K; Roth N; Choong K; Cooper D; Han A, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, 15, pp. 326, http://dx.doi.org/10.1186/s12879-015-1051-4
2015
Petoumenos K; Watson J; Whittaker B; Hoy J; Smith D; Bastian L; Finlayson R; Sloane A; Wright ST; McManus H; Law MG; Han A, 2015, 'Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: Results from the Australian HIV Observational Database Temporary Residents Access Study', Journal of the International AIDS Society, 18, pp. 19392, http://dx.doi.org/10.7448/IAS.18.1.19392
2015
Miller CJ; Baker JV; Bormann AM; Erlandson KM; Hullsiek KH; Justice AC; Neuhaus J; Paredes R; Petoumenos K; Wentworth D; Winston A; Wolfson J; Neaton JD; Emery S, 2014, 'Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy', PLoS ONE, 9, pp. e95061, http://dx.doi.org/10.1371/journal.pone.0095061
2014
McManus H; Petoumenos K; Franic T; Kelly MD; Watson J; O’Connor CC; Jeanes M; Hoy J; Cooper DA; Law MG; O'Connor C; Templeton D; Han A, 2014, 'Determinants of Suicide and Accidental or Violent Death in the Australian HIV Observational Database', PLoS ONE, 9, pp. e89089 - e89089, http://dx.doi.org/10.1371/journal.pone.0089089
2014
Achhra AC; Petoumenos K; Law MG, 2014, 'Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals', Current Opinion in HIV and AIDS, 9, pp. 63 - 71, http://dx.doi.org/10.1097/COH.0000000000000017
2014
Petoumenos K; Reiss P; Ryom L; Rickenbach M; Sabin CA; El-Sadr W; d'Arminio Monforte A; Phillips AN; De Wit S; Kirk O; Dabis F; Pradier C; Lundgren JD; Law MG, 2014, 'Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: A comparison of the D: A: D CVD risk equation and general population CVD risk equations', HIV Medicine, http://dx.doi.org/10.1111/hiv.12162
2014
Rafiee M; Kariminia A; Wright S; Mills G; Woolley I; Smith D; Templeton DJ; Law MG; Petoumenos K, 2014, 'Reducing Viral Load Measurements to Once a Year in Patients on Stable, Virologically Suppressive Cart Regimen: Findings from the Australian HIV Observational Database', Journal of AIDS & Clinical Research, 5, pp. 383, http://dx.doi.org/10.4172/2155-6113.1000383
2014
Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ; Dolan K, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010
2014
Wright ST; Hoy J; Mulhall B; OʼConnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA; O'Connor C, 2014, 'Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy', JAIDS Journal of Acquired Immune Deficiency Syndromes, 66, pp. 55 - 64, http://dx.doi.org/10.1097/QAI.0000000000000125
2014
Kamara DA; Ryom L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; Fux CA; Mocroft A; Sabin C; Lundgren JD; Smith CJ; Powderly B; Shortman N; Moecklinghoff C; Reilly G; Franquet X; Ryom L; Sabin CA; Kamara D; Smith C; Phillips A; Mocroft A; Tverland J; Mansfeld M; Nielsen J; Raben D; Lundgren JD; Salbøl Brandt R; Rickenbach M; Fanti I; Krum E; Hillebregt M; Geffard S; Sundström A; Delforge M; Fontas E; Torres F; McManus H; Wright S; Kjær J; Sjøl A; Meidahl P; Helweg-Larsen J; Schmidt Iversen J; Mocroft A; Ross M; Morlat P; Kesselring AM; Smith C; Smith C; Phillips A; Weber R; Morlat P; Pradier C; Friis-Møller N; Kowalska J; Sabin C; Law M; D'Arminio Monforte A; Dabis F; Bruyand M; Smith C; Bower M; Fätkenheuer G; Donald A; Grulich A; Zaheri S; Gras L; Prins JM; Kuijpers TW; Scherpbier HJ; Van Der Meer JTM; Wit FWMN; Godfried MH; Reiss P; Van Der Poll T; Nellen FJB; Lange JMA; Geerlings SE; Van Vugt M; Pajkrt D; Bos JC; Van Der Valk M, 2014, 'Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study', BMC Nephrology, 15, http://dx.doi.org/10.1186/1471-2369-15-51
2014
Mulhall BP; Wright S; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Read P; Read T; Russell D; Smith DJ; Templeton DJ; Fairley CK; Law MG; Han A, 2014, 'High rates of sexually transmissible infections in HIV-positive patients in the Australian HIV Observational Database: A prospective cohort study', Sexual Health, 11, pp. 291 - 297, http://dx.doi.org/10.1071/SH13074
2014
Petoumenos K; Reiss P; Ryom L; Rickenbach M; Sabin CA; El-Sadr W; d'Arminio Monforte A; Phillips AN; De Wit S; Kirk O; Dabis F; Pradier C; Lundgren JD; Law MG, 2014, 'Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: A comparison of the D: A: D CVD risk equation and general population CVD risk equations', HIV Medicine, 15, pp. 595 - 603, http://dx.doi.org/10.1111/hiv.12162
2014
Kovari H; Sabin CA; Ledergerber B; Ryom L; Smith C; Phillips A; Reiss P; Fontas E; Petoumenos K; De Wit S; Morlat P; Lundgren JD; Weber R, 2013, 'Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: The data collection on adverse events of anti-HIV drugs study', Clinical Infectious Diseases, 56, pp. 870 - 879, http://dx.doi.org/10.1093/cid/cis919
2013
Rotger M; Glass TR; Junier T; Lundgren J; Neaton JD; Poloni ES; Van 'T Wout AB; Lubomirov R; Colombo S; Martinez R; Rauch A; Günthard HF; Neuhaus J; Wentworth D; Van Manen D; Gras LA; Schuitemaker H; Albini L; Torti C; Jacobson LP; Li X; Kingsley LA; Carli F; Guaraldi G; Ford ES; Sereti I; Hadigan C; Martinez E; Arnedo M; Egaña-Gorroño L; Gatell JM; Law M; Bendall C; Petoumenos K; Rockstroh J; Wasmuth JC; Kabamba K; Delforge M; De Wit S; Berger F; Mauss S; De Paz Sierra M; Losso M; Belloso WH; Leyes M; Campins A; Mondi A; De Luca A; Bernardino I; Barriuso-Iglesias M; Torrecilla-Rodriguez A; Gonzalez-Garcia J; Arribas JR; Fanti I; Gel S; Puig J; Negredo E; Gutierrez M; Domingo P; Fischer J; Fätkenheuer G; Alonso-Villaverde C; MacKen A; Woo J; McGinty T; Mallon P; Mangili A; Skinner S; Wanke CA; Reiss P; Weber R; Bucher HC; Fellay J; Telenti A; Tarr PE, 2013, 'Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons', Clinical Infectious Diseases, 57, pp. 112 - 121, http://dx.doi.org/10.1093/cid/cit196
2013
Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; Wit SD; Phillips A; Lundgren JD; Sabin CA; Butcher D; Delforge M; Fanti I; Franquet X; Geffard S; Gras L; Helweg-Larsen J; Hillebregt M; Kamara D; Kjær J; Krum E; McManus H; Meidahl P; Mocroft A; Nielsen J; Powderl W; Rickenbach M; Rode R; Ryom L; Salbøl Brandt R; Schmidt Iversen J; Shortman N; Sjøl A; Smith C; Torres F; Tverland J; Wright S; Zaheri S; de Wolf F; Smidt J; Ristola M; Katlama C; Viard JP; Girard PM; Livrozet JM; Vanhems P; Pradier C; Dabis F; Neau D; Rockstroh J; Schmidt R; Degen O; van Lunzen J; Stellbrink HJ; Staszewski S; Bogner J; Gargalianos P; Kosmidis J; Perdios J; Xylomenos G; Filandras A; Karabatsaki E; Panos G; Sambatakou H; Banhegyi D; Mulcahy F; Burke M; Turner D; Yust I; Hassoun G; Pollack S; Maayan S; Vella S; Esposito R; Mazeu I; Mussini C; Arici C; Pristera R; Gabbuti A; Mazzotta F; Lichtner M; Vullo V; Boer K; Geerlings SE; Godfried MH; Kuijpers TW; Lange JMA; Nellen FJB; Pajkrt D; Prins JM; Scherpbier HJ; Vrouenraets SME; Wit FWMN; van Vugt M; Cooper D; Petoumenos K; Carr A; Bloch M; Han A, 2013, 'Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study', BMC Infectious Diseases, 13, pp. 471, http://dx.doi.org/10.1186/1471-2334-13-471
2013
Grebely J; Feld JJ; Applegate T; Matthews GV; Hellard M; Sherker A; Petoumenos K; Zang G; Shaw I; Yeung B; George J; Teutsch S; Kaldor JM; Cherepanov V; Bruneau J; Shoukry NH; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection', Hepatology, 57, pp. 2124 - 2134, http://dx.doi.org/10.1002/hep.26263
2013
Feld JJ; Grebely J; Matthews GV; Applegate T; Hellard M; Sherker A; Cherepanov V; Petoumenos K; Yeung B; Kaldor JM; Lloyd AR; Dore GJ, 2013, 'Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection', PLoS ONE, 8, pp. e80003, http://dx.doi.org/10.1371/journal.pone.0080003
2013
Wright ST; Petoumenos K; Boyd MA; Carr AD; Downing S; O''connor C; Grotowski M; Law MG, 2013, 'Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience', HIV Medicine, 14, pp. 208 - 216, http://dx.doi.org/10.1111/j.1468-1293.2012.01053.x
2013
Wright S; Boyd MA; Yunihastuti E; Law M; Sirisanthana T; Hoy J; Pujari S; Lee MP; Petoumenos K; Templeton D; Han A, 2013, 'Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region', PLoS ONE, 8, pp. e64902, http://dx.doi.org/10.1371/journal.pone.0064902
2013
Byakwaga H; Petoumenos K; Ananworanich J; Zhang F; Boyd MA; Sirisanthana T; Li PCK; Lee C; Mean CV; Saphonn V; Omar SFS; Pujari S; Phanuphak P; Lim PL; Kumarasamy N; Chen YMA; Merati TP; Sungkanuparph S; Ditangco R; Oka S; Tau G; Zhou J; Law MG; Emery S; Han A, 2013, 'Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database', Journal of the International Association of Providers of AIDS Care, 12, pp. 270 - 277, http://dx.doi.org/10.1177/1545109712469684
2013
Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA, 2013, 'Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV', AIDS, 27, pp. 1245 - 1251, http://dx.doi.org/10.1097/QAD.0b013e32835e163d
2013
Petoumenos K; Van Leeuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG, 2013, 'Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD)', HIV Medicine, 14, pp. 77 - 84, http://dx.doi.org/10.1111/j.1468-1293.2012.01038.x
2013
Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Moller N; Lundgren JD; Law MG; Law M; Han A, 2012, 'Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study', Journal of the International AIDS Society, 15, pp. Article number17426, http://dx.doi.org/10.7448/IAS.15.2.17426
2012
Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M; Van Beek I; Amin J; Dolan K; Rawlinson W; Flynn J; Marks P; Acraman B; Bloch M; Li H; Madden A; George J, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x
2012
Machalek DA; Poynten IM; Jin F; Fairley CK; Farnsworth A; Garland S; Hillman R; Petoumenos K; Roberts J; Tabrizi S; Templeton DJ; Grulich AE, 2012, 'Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: A systematic review and meta-analysis', Lancet Oncology, 13, pp. 487 - 500, http://dx.doi.org/10.1016/S1470-2045(12)70080-3
2012
Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G; Dolan K, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719
2012
McManus H; O'Connor CC; Boyd MA; Broom J; Russell D; Watson K; Roth N; Read PJ; Law M; Petoumenos K; Templeton D; Han A, 2012, 'Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy', PLoS One, 7, pp. Article numbere48839, http://dx.doi.org/10.1371/journal.pone.0048839
2012
Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull ; Dolan K, 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754
2012
Jansson J; Wilson D; Carr A; Petoumenos K; Boyd M, 2012, 'Currently available medications may not be sufficient for lifelong treatment of HIV', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 15, pp. 4 - 4, http://dx.doi.org/10.7448/IAS.15.6.18077
2012
, 2012, 'Eleventh International Congress on Drug Therapy in HIV Infection', Journal of the International AIDS Society, 15, pp. 18447 - 18447, http://dx.doi.org/10.7448/ias.15.6.18447
2012
Grebely J; Alavi M; Spelman T; Haber P; Day C; Matthews G; Van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Kaldor J; Dore G; Hellard M, 2012, 'IMPACT OF TREATMENT OF RECENTLY-ACQUIRED HEPATITIS C INFECTION ON INJECTING DRUG USE BEHAVIOURS', DRUG AND ALCOHOL REVIEW, 31, pp. 34 - 34
2012
Petoumenos K; Worm SW, 2011, 'HIV infection, ageing and cardiovascular disease: Epidemiology and prevention', Sexual Health, 8, pp. 465 - 473, http://search.informit.com.au/documentSummary;dn=535450990470779;res=IELHEA
2011
Worm SW; Kamara DA; Reiss P; Kirk O; El-Sadr W; Fux C; Fontas E; Phillips A; D''arminio Monforte A; De Wit S; Petoumenos K; Friis-Moller N; Mercie P; Lundgren JD; Sabin C, 2011, 'Elevated triglycerides and risk of myocardial infarction in HIV-positive persons', AIDS, 25, pp. 1497 - 1504, http://dx.doi.org/10.1097/QAD.0b013e32834917c6
2011
Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T, 2011, 'Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression', Vaccine, 29, pp. 2962 - 2967, http://dx.doi.org/10.1016/j.vaccine.2011.01.114
2011
Rajasuriar R; Gouillou M; Spelman T; Read T; Hoy JF; Law MG; Cameron P; Petoumenos K; Lewin S, 2011, 'Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the australian HIV observational database', PLoS One, 6, pp. e20713, http://dx.doi.org/10.1371/journal.pone.0020713
2011
Petoumenos K; Worm S; Reiss P; De Wit S; D''arminio monforte A; Sabin C; Friis-Moller N; Weber R; Mercie P; Pradier C; El-Sadr W; Kirk O; Lundgren JD; Law MG, 2011, 'Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study', HIV Medicine, 12, pp. 412 - 421, http://dx.doi.org/10.1111/j.1468-1293.2010.00901.x
2011
Van Bockel DJ; Ammaranond P; Petoumenos K; Mcmurchie M; Finlayson RJ; Middleton MG; Davenport ; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD, 2011, 'HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome', Journal of Immunology, 186, pp. 479 - 488, http://www.jimmunol.org/content/186/1/479
2011
Law MG; Woolley I; Templeton DJ; Roth N; Chuah J; Mulhall BP; Canavan P; Mcmanus H; Cooper DA; Petoumenos K, 2011, 'Trends in detectable viral load by calendar year in the Australian HIV observational database', Journal of the International AIDS Society, 14, pp. 10, http://dx.doi.org/10.1186/1758-2652-14-10
2011
Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033
2011
McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x
2011
Achhra AC; Zhou J; Choi JY; Hoy J; Zhang F; Templeton DJ; Merati T; Woolley I; Petoumenos K; Amin J, 2011, 'The clinical significance of CD4 counts in asian and caucasian HIV-infected populations: Results from TAHOD and AHOD', Journal of the International Association of Physicians in AIDS Care, 10, pp. 160 - 170, http://dx.doi.org/10.1177/1545109711402213
2011
Marashi Pour S; Woolley I; Canavan P; Chuah J; Russell DB; Law MG; Petoumenos K, 2011, 'Triple Class Experience after Initiation of Combination Antiretroviral Treatment in Australia: Survival and Projections', Sexual Health, 8, pp. 295 - 303, http://search.informit.com.au/documentSummary;dn=359164449396949;res=IELHEA
2011
Bunupuradah T; Ananworanich J; Chetchotisakd P; Kantipong P; Jirajariyavej S; Sirivichayakul S; Munsakul W; Prasithsirikul W; Sungkanuparph S; Bowonwattanuwong C; Klinbuayaem V; Petoumenos K; Hirschel B; Bhakeecheep S; Ruxrungtham K, 2011, 'Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens', Antiviral Therapy, 16, pp. 1113 - 1121, http://dx.doi.org/10.3851/IMP1906
2011
Petoumenos K; Hui E; Kumarasamy N; Kerr SJ; Choi JY; Chen YF; Merati T; Zhang F; Lim P; Sungkanuparph S; Pujari S; Ponnampalavanar S; Ditangco R; Lee CK; Grulich AE; Law MG, 2010, 'Cancers in the Treat Asia HIV Observational Database (TAHOD): A retrospective analysis of risk factors', Journal of the International AIDS Society, 13, pp. 1 - 14, http://www.jiasociety.org/content/13/1/51
2010
Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ; Amin J; Cameron B; Acraman B; Dolan K; Bloch M; Van Beek I; Li H; Madden A, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850
2010
Puls R; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe CJ; Belloso WH; Molina J; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S, 2010, 'Efavirenz versus boosted atazanavir or zidovudine and abacavir in antirectroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study', Clinical Infectious Diseases, Oct 1; 51, pp. 855 - 864
2010
Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', PLoS ONE, 11, pp. e0160673, http://dx.doi.org/10.1371/journal.pone.0160673
2010
Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015
2010
Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019
2010
Carey DL; Amin J; Boyd MA; Petoumenos K; Emery S, 2010, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomised controlled trials', Journal of Antimicrobial Chemotherapy, 65, pp. 1878 - 1888
2010
Winston A; Duncombe C; Li P; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA, 2010, 'Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study', Clinical Infectious Diseases, 50, pp. 920 - 929
2010
Grebely J; Matthews GV; Petoumenos K; Dore GJ, 2010, 'Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection', Journal of Viral Hepatitis, 17, pp. 896, http://dx.doi.org/10.1111/j.1365-2893.2009.01256.x
2010
Egger S; Petoumenos K; Kamarulzaman A; Hoy JF; Sungkanuparph S; Chuah J; Falster KA; Zhou J; Law MG, 2009, 'Long term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load and time: The Asia Pacific HIV Observational Database (APHOD)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 513 - 520
2009
Byakwaga H; Zhou J; Petoumenos K; Law MG; Boyd MA; Emery S; Cooper DA; Mallon PW, 2009, 'Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy', HIV Medicine, 10, pp. 143 - 151
2009
Carey DL; Baker D; Petoumenos K; Chuah J; Rogers G; Watson J; Cooper DA; Emery S; Carr AD, 2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, 10, pp. 163 - 172
2009
Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576
2009
Puls R; Srasuebkul P; Petoumenos K, 2009, 'Anthropometric and metabolic outcomes in a 48-week randomized, open-label study of three different combination antiretroviral regimens as initial therapy for HIV infection', Antiviral Therapy, 14, pp. A8 - A9
2009
Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072
2009
Falster KA; Petoumenos K; Chuah J; Mijch AM; Mulhall BP; Kelly M; Cooper DA, 2009, 'Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression.', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 50, pp. 307 - 313
2009
Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; Van Beek I; Kaldor J; Dore GJ, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', DRUG AND ALCOHOL REVIEW, 28, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Sabin CA; Worm SW; Weber R; Reiss P; El-Sadr W; Dabis F; De Wit S; Law M; D'Arminio Monforte A; Friis-Møller N; Kirk O; Pradier C; Weller I; Phillips AN; Lundgren JD; Collins S; Rosseau F; Storfer SP; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J, 2008, 'Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: A multi-cohort collaboration', The Lancet, 371, pp. 1417 - 1426, http://dx.doi.org/10.1016/S0140-6736(08)60423-7
2008
Monforte A; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law MG; de Witt S; Friis-Moller N; Phillips AN; Sabin C; Lundgren JD, 2008, 'HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.', AIDS, pp. 2143 - 2153
2008
Falster KA; Gelgor L; Shaik A; Zablotska Manos I; Prestage G; Grierson J; Thorpe R; Pitts M; Anderson JS; Chuah J; Mulhall BP; Petoumenos K; Kelleher AD; Law MG, 2008, 'Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment', Sexual Health, 5, pp. 141 - 154
2008
Byakwaga H; Murray JM; Petoumenos K; Boyd MA; Emery S; Mallon PW; Cooper DA, 2008, 'Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p70
2008
Petoumenos K; Fontas E; Worm SW; Weber R; De Wit S; Bruyand M; Sabin CA; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG, 2008, 'O314 Predicting the short-term risk of diabetes in HIV-infected patients in the D:A:D cohort: the D:A:D study group', Journal of the International AIDS Society, 11, pp. O30 - O30, http://dx.doi.org/10.1186/1758-2652-11-s1-o30
2008
Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589
2007
Calmy A; Petoumenos K; Lewden C; Law MG; Bocquentin F; Hesse K; Cooper DA; Carr AD; Bonnet F, 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts', HIV Medicine, 8, pp. 171 - 180
2007
Dore GJ; Hellard M; Matthews G; Haber PS; Shaw D; Yeung B; Petoumenos K; Van Beek IA; Mccaughan GW; Pan Y; Ffrench R; Rowlinson W; Lloyd AR; Kaldor JM, 2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A
2007
Drake A; Loy CT; Brew BJ; Chen TP; Petoumenos K; Li P; Wright E, 2007, 'Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival', European Journal of Neurology, 14, pp. 418 - 423
2007
Law MG; Friis-Moller N; El-Sadr W; Weber RO; Reiss P; Monforte A; Thiebaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Kirk O; Sabin C; Phillips AN; Lundgren JD, 2006, 'The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D : A : D Study', HIV Medicine, 7, pp. 218 - 230
2006
Collins S; Mertenskoetter T; Loeliger E; Tressler R; Weller I; Friis-Møller N; Worm SW; Sabin CA; Sjøl A; Lundgren JD; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Gras L; Balestre E; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Weber R; Reisswafaamel-Sadr P; Kirk O; Dabis F; Law MG; Pradier C; De Wit S; Akerlund B; Calvo G; Monforte ADA; Ledergerber B; Phillips AN; De Wolf F; Zaheri S; Bronsveld W; Hillebrand-Haverkort ME; Prins JM; Bos JC; Schattenkerk JKME; Geerlings SE; Godfried MH; Lange JMA; Van Leth FC; Lowe SH; Van Der Meer JTM; Nellen FJB; Pogány K; Van Der Poll T; Reiss P; Ruys TA; Sankatsing SU; Steingrover R; Van Twillert G; Van Der Valk M; Van Vonderen MGA; Vrouenraets SME; Van Vugt MV; Wit FWMN; Van Eeden A; Ten Veen JH; Van Dam PS; Roos JC; Brinkman K; Frissen PHJ; Weigel HM; Mulder JW; Van Gorp ECM; Meenhorst PL; Mairuhu ATA; Veenstra J; Danner SA; Van Agtmael MA; Claessen FAP; Perenboom RM; Rijkeboer A; Richter C; Van Der Berg J; Van Leusen R; Vriesendorp R; Jeurissen FJF; Kauffmann RH; Koger ELW; Bravenboer B; Ten Napel CHH; Kootstra GJ; Sprenger HG; Miesen WMAJ; Doedens R; Scholvinck EH; Ten Kate RW; Van Houte DPF; Polee M; Kroon FP; Van Den Broek PJ; Van Dissel JT; Schippers EF; Schreij G; Van De Geest S, 2006, 'Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study', Archives of Internal Medicine, 166, pp. 1632 - 1641, http://dx.doi.org/10.1001/archinte.166.15.1632
2006
Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 42, pp. 192 - 202
2006
Petoumenos K; Law MG, 2006, 'Risk factors and causes of death in the Australian HIV Observational Database. Sex Health', Sexual Health, 3, pp. 103 - 112
2006
Zhou J; Kumarasamy N, 2005, 'Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD)', HIV Medicine, 6, pp. 216 - 223
2005
Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163
2005
Fontas E; van Leth F; Sabin C; Friis-Moller N; Rickenbach M; Monforte A; Kirk O; Dupon M; Morfeldt L; Mateu S; Petoumenos K; El-Sadr W; De Wit S; Lundgren JD; Pradier C; Reiss P, 2004, 'Lipid profiles in HIV-infected patients receiving combinationantiretroviral therapy: Are different antiretroviral drugs associatedwith different lipid profiles?', Journal of Infectious Diseases, 189, pp. 1056 - 1074
2004
d'Arminio A; Sabin CA; Phillips AN; Reiss P; Weber R; Kirk O; El-Sadr W; De Wit S; Mateu S; Petoumenos K; Dabis F; Pradier C; Morfeldt L; Lundgren JD; Friis-Møller N; Writing Committee of the D:A:D: Study Group , 2004, 'Cardio- and cerebrovascular events in HIV-infected persons.', AIDS, 18, pp. 1811 - 1817, http://dx.doi.org/10.1097/00002030-200409030-00010
2004
Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6
2004
Petoumenos K; Carr AD, 2003, 'The role of observational data in monitoring trends in antiretroviral treatment and HIV disease stage: results from the Australian HIV Observational database', Journal of Clinical Virology, 26, pp. 209 - 222
2003
Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249
2003
Friis-Møller N; Sabin CA; Weber R; d'Arminio Monforte A; El-Sadr WM; Reiss P; Thiébaut R; Morfeldt L; De Wit S; Pradier C; Calvo G; Law MG; Kirk O; Phillips AN; Lundgren JD; Bartsch G; Dabis F; Houyez F; Loeliger E; Tressler R; Weller I; Sjøl A; Sawitz A; Rickenbach M; Pezzotti P; Krum E; Meester R; Lavignolle V; Sundström A; Poll B; Fontas E; Torres F; Petoumenos K; Kjær J; Hammer S; Neaton J; de Wolf F; van der Ven E; Zaheri S; Van Valkengoed I; Bronsveld W; Weigel H; Brinkman K; Frissen P; ten Veen J; Hillebrand M; van Dam P; Schieveld S; Mulder J; van Gorp E; Meenhorst P; van Eeden A; Danner S; Claessen F; Perenboom R; Eeftinck Schattenkerk JK; Godfried M; Lange J; Lowe S; van der Meer J; Nellen F; Pogany K; van der Poll T; Prins J; Ruys T; van der Valk M; Wit F; Richter C; van Leusen R; Vriesendorp R; Jeurissen F; Kauffmann R; Koger E; Bravenboer B; ten Napel C; Sprenger HG; Law G; ten Kate RW; Leemhuis M; Kroon F; Schippers E; Schrey G; van der Geest S; Verbon A; Koopmans P; Keuter M; Telgt D; van der Ven A; van der Ende M; Gyssens I; de Marie S; Juttmann J; van der Heul C; Schneider M; Borleffs J; Hoepelman I; Jaspers C; Matute A; Schurink C, 2003, 'Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group', New England Journal of Medicine, 349, pp. 1993 - 2003, http://dx.doi.org/10.1056/NEJMoa030218
2003
Knox J; Tabrizi S; Miller P; Petoumenos K; Law MG; Chen S; Garland S, 2002, 'Evaluation of self-collected samples in contrast to practitioner collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas', Sexually Transmitted Diseases, 29, pp. 647 - 654
2002
Baker D; Law MG; Petoumenos K; Smith DE; Anderson JA; Roth N; Mallal SA, 2002, 'Rates of combination antiretroviral treatment change in Australia, 1997-2000', HIV Medicine, 3, pp. 28 - 36
2002
Carr AD; Law MG; Baker D; Petoumenos K; Smith D; Anderson JA; Roth N; Mallal SS, 2002, 'Rates of combination antiretroviral treatment change in Australia', HIV Medicine, 3, pp. 28 - 36
2002
Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 162 - 168
2001
Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia, http://dx.doi.org/10.1101/2023.08.17.23293358
2023
King J; Petoumenos K; Dobbins T; Guy RJ; Gray RT; Nigro SJ; Si D; Minas B; McGregor S, 2022, A population level application of a novel method for estimating the timing of HIV acquisition among migrants to Australia (Preprint), http://dx.doi.org/10.2196/preprints.40543
2022
Dharan N; Yeh P; Bloch M; Yeung M; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy J; Woolley I; Pell C; Templeton D; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson S-J; Polizzotto M; Dawson M; for the ARCHIVE Study Group , 2020, Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study, http://dx.doi.org/10.1101/2020.11.19.20235069
2020
Dawson M; Dharan N; Yeh P; Bloch M; Yeung M; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy J; Woolley I; Pell C; Templeton D; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson S-J; Polizzotto M, 2020, Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study, http://dx.doi.org/10.21203/rs.3.rs-106576/v1
2020
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Rowling D; Doong N; Jackson E; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, Moving Towards HCV Elimination Among People Living with HIV in Australia: Analysis of the CEASE Prospective Cohort Study, http://dx.doi.org/10.2139/ssrn.3269607
Alvarez H; Mocroft A; Ryom L; Neesgaard B; Edwards S; Svedhem-Johansson V; Gunthard H; Zangerle R; Smith C; Castagna A; Monforte AD; Wit F; Stecher M; Lehman C; Mussini C; Fontas E; Gonzalez E; Wasmuth J-C; Sonnerborg A; De Wit S; Chkhartishvili N; Stephan C; Petoumenos K; Jaschinski N; Vannappagari V; Rooney J; Young L; Anne AV; Greenberg L; Martin-Iguacel R; Poveda E; Llibre J, 2022, 'Initial plasma HIV-1 RNA and CD4+T-cell count are determinants of virological outcomes with initial integrase inhibitor-based regimens: a prospective multinational RESPOND cohort consortium', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 25, pp. 199 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870695800245&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Jaschinski N; Neesgaard B; Wit F; van der Valk M; Gunthard H; Stockle M; Wallner E; Kowalska J; Ridolfo A; Nowak P; Castagna A; Monforte AD; Chkhartishvili N; Petoumenos K; Hoy J; Garges H; Rooney J; Young L; Hosein S; Lundgren J; Peters L; Mocroft A; Ryom L, 2022, 'Use of preventive measures for cardiovascular disease in people living with HIV', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 25, pp. 3 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870695800006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2022
Matthews G; Bhagani S; Van der Valk M; Rockstroh JK; Kim AY; Thurnheer C; Feld JJ; Bruneau J; Gane EJ; Hellard M; Grebely J; Applegate T; Marks P; Martinello M; Petoumenos K; Dore G, 2019, 'SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDY', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 1487A - 1488A, presented at 70th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000500824000056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthew G, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Martinello M; Cerrone M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Schoolmeesters A; Grebely J; Nelson M; Matthews GV, 2018, 'TARGET3D: high efficacy of 8 weeks paritaprevir/ritonavir/ombitasvir and dasabuvir among people with recent genotype 1 HCV infection', in HIV MEDICINE, WILEY, Vol. 19, pp. S151 - S152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430174700440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Martinello M; Bhagani S; Gane EJ; Orkin C; Cooke G; Kulasegaram R; Shaw D; Hellard M; Tu E; Filep E; Petoumenos K; Marks P; Grebely J; Dore GJ; Nelson M; Matthews G, 2017, 'Shortened therapy of 8 weeks duration with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with acute and recent genotype 1 HCV infection: The TARGET3D Study', in HEPATOLOGY, WILEY, DC, Washington, Vol. 66, pp. 574A - 575A, presented at 68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, DC, Washington, 20 October 2017 - 24 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000412089801215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Martinello M; Petoumenos K; Grebely J; Gane E; Hellard M; Shaw D; Sasdeusz J; Applegate T; Lamoury F; Yeung B; Maire L; Dore G; Matthews G, 2016, 'INCIDENCE OF HCV REINFECTION AMONG TREATED INDIVIDUALS WITH RECENTLY ACQUIRED INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, SPAIN, Barcelona, Vol. 64, pp. S620 - S621, presented at EASL International Liver Congress, SPAIN, Barcelona, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)01152-1
2016
Petoumenos K, 2015, The Australian HIV Observational Database Temporary Residents Access Study (ATRAS)
2015
Falster K; Law MG; Petoumenos K, 2006, Australian HIV Observational Database Annual Report 2006
2006
Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2014, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 425 - 434, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP3035
2014
McMahon CN; Petoumenos K; Hesse K; Cooper DA; Carr A; Samaras K, 2014, 'Incident Glucose Disorders and All-Cause Mortality at 15 Years in Treated HIV-Infection', in ENDOCRINE REVIEWS, ENDOCRINE SOC, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209805106300&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Grebely J; Feld JJ; Applegate T; Matthews G; Hellard M; Sherker A; Petoumenos K; Shaw I; Yeung B; Kaldor JM; Cherepanov V; Bruneau J; Lloyd A; Shoukry N; Dore G, 2012, '889 PLASMA IP10 LEVEL PREDICTS SPONTANEOUS CLEARANCE IN ACUTE HCV INFECTION', in Journal of Hepatology, Elsevier, SPAIN, Barcelona, pp. s346, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/s0168-8278(12)60901-5
2012
Feld JJ; Grebely J; Applegate T; Matthews GV; Hellard M; Suppiah V; Sherker A; Petoumenos K; Shaw I; Yeung B; Rawlinson W; Booth D; Kaldor JM; Lloyd AR; Dore GJ, 2011, 'IP-10 IS ASSOCIATED WITH EARLY VIRAL KINETICS, BUT NOT SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S455 - S455, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)61154-9
2011
Grebely J; Matthews GV; Hellard M; Suppiah V; Petoumenos K; Applegate T; Yeung B; Rawlinson W; Feld J; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ, 2011, 'IL28B GENOTYPE HAS VARIABLE INFLUENCE ON EARLY VIRAL KINETICS, BUT NO INFLUENCE ON SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S524 - S524, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)61330-5
2011
Grebely J; Alavi M; Haber P; Day C; Matthews GV; van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Spelman T; Kaldor JM; Dore GJ; Hellard M, 2011, 'IMPACT OF TREATMENT ON INJECTING DRUG USE BEHAVIORS DURING RECENT HCV INFECTION: THE ATAHC STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S174 - S174, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60431-5
2011
Matthews GV; Alavi M; Grebely J; Petoumenos K; Yeung B; Hellard M; Lloyd A; van Beek I; Kaldor J; Haber P; Dore GJ, 2010, 'Depression prior to and during treatment for recent hepatitis C virus (HCV) infection among HCV and HCV/HIV participants in the ATAHC study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A21 - A21, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Matthews GV; Alavi M; Grebely J; Petoumenos K; Yeung B; Hellard M; Lloyd A; van Beek I; Kaldor J; Haber P; Dore GJ, 2010, 'Depression prior to and during treatment for recent hepatitis C virus (HCV) infection among HCV and HCV/HIV participants in the ATAHC study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A21 - A21, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan GW; White PA; Ffrench RA; Rawlinson W; Lloyd AR; Kaldor J, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 723A - 723A, presented at 60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 30 October 2009 - 03 November 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270456000887&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Puls RL; Srasuebkul P; Petoumenos K; Emery S; Cooper DA, 2009, 'Anthropometric and metabolic outcomes in a 48-week randomized, open-label study of three different combination antiretroviral regimens as initial therapy for HIV infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A8 - A9, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009
Hellard M; Matthews G; Petoumenos K; Grebely J; Haber PS; Van Beek IA; Marks P; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Factors associated with uptake of treatment for acute and early chronic hepatitis C virus infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A344 - A344
2008
Hellard M; Grebely J; Matthews G; Haber PS; Petoumenos K; Yeung B; Van Beek IA; Lloyd AR; Kaldor JM; Dore GJ, 2008, 'Impact of illicit drug use on response to therapy during treatment for acute and early chronic HCV infection', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A337 - A338
2008
Falster KA; Petoumenos K; Law MG; Cooper DA, 2008, 'Country review: Australia.', in Zuniga JM; Whiteside A; Ghaziani A; Bartlett JG (ed.), A Decade of HAART: The Development and Global Impact of Highly Active Antiretroviral Therapy., Oxford University Press, Oxford, pp. 85 - 101
2008
Glenday K; Petoumenos K; Chuah J; Mijch A; Mulhall B; Kelly M; Cooper DA, 2007, 'Predictors of poor immune response to highly active antiretroviral therapy in patients with a sustained virological response: The Australian HIV Observational Database 1999-2006', presented at 4th International AIDS Society Conference, Sydney, Australia, -
2007